cms_HI: 88
In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.
This data as json, copyable
|
rowid
|
facility_name
|
facility_id
|
address
|
city
|
state
|
zip
|
inspection_date
|
deficiency_tag
|
scope_severity
|
complaint
|
standard
|
eventid
|
inspection_text
|
filedate
|
| 88 |
MALUHIA |
125009 |
1027 HALA DRIVE |
HONOLULU |
HI |
96817 |
2017-06-02 |
428 |
D |
0 |
1 |
HXLB11 |
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on medical record reviews and staff interviews the facility failed to review medications in collaboration with the MD for 1 of 24 residents (R#84) on the Stage 2 survey sample residents list. Findings include: On 06/01/2017 at 8:38 AM the MRR on R#84 found on the (MONTH) (YEAR) physician order [REDACTED]. for the [DIAGNOSES REDACTED]. The facility's pharmacist review dated 5/15/17 noted, 5/3 decrease (drawn arrow pointing down); 5/3 INR 3.1 re-titrate; MD Warfarin update. The lab results for PT/INR done on 5/03/17, had results of , PT 31.8 secs/ INR 3.1. The physician telephone order on 5/3/17 noted, Coumadin 1 mg PO on MWFSS and 2 mg PO on TTH. Check Protime in 1 month. The MD progress notes on 5/18/17 for the recertification visit noted on the, Plan: On coumadin cont medication. Adjust dose as indicated. Q 2 week INR checks .; Medications ordered: Warfarin 2 mg oral tab; Sig - route: Take 1 tablet by mouth once daily on T, TH, Sa, Su and take 1/2 tab on the other days for thinning the blood . Interviewed Staff#24 to clarify discrepancy of Jun 17 PO and MD visit on 5/18/17 with different orders for Warfarin. Staff#24 had to check with the MD as could not find documentation that new order was clarified with MD. MD report was faxed to facility on 5/22/17 12:36:54 AM. The IDT progress notes on 5/28/17 noted that the MD was notified & staff received telephone order for [NAME]itussin DM Q 6 hr for cough as R#84 was coughing/wheezy earlier that day. The residents CP#13, I am at risk for possible SE r/t use of Warfarin, included interventions: 1. Provide medication as ordered. (Warfarin Na). Observe for side effects like bleeding, behavioral changes, skin rashes, etc, document and notify MD as indicated. Lab works as indicated. Notify MD for changes. 3. Check my skin every shift and monitor for early signs of skin breakdown like redness blisters, rashes, bruises or an signs of bleeding, document and notify MD as indicated 5. refer to Pharmacy/MD for drug review and follow recommendations. The facility failed to ensure that R#84 was administered the correct dosage of Coumadin as prescribed. |
2020-09-01 |